Filing Details
- Accession Number:
- 0001209191-18-034168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-30 17:01:12
- Reporting Period:
- 2018-05-30
- Accepted Time:
- 2018-05-30 17:01:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1659323 | Iterum Therapeutics Plc | ITRM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1553594 | N. Corey Fishman | C/O Iterum Therapeutics Plc, Blk 2 Fl. 3, Harcourt Centre, Harcourt St. Dublin L2 2 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-05-30 | 33,259 | $0.00 | 229,312 | No | 4 | C | Direct | |
| Ordinary Shares | Acquisiton | 2018-05-30 | 4,050 | $0.00 | 233,362 | No | 4 | C | Direct | |
| Ordinary Shares | Acquisiton | 2018-05-30 | 1,591 | $0.00 | 234,953 | No | 4 | C | Direct | |
| Ordinary Shares | Acquisiton | 2018-05-30 | 3,000 | $13.00 | 237,953 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Series A Preferred Shares | Disposition | 2018-05-30 | 33,259 | $0.00 | 33,259 | $0.00 |
| Ordinary Shares | Series B-1 Preferred Shares | Disposition | 2018-05-30 | 4,050 | $0.00 | 4,050 | $0.00 |
| Ordinary Shares | Series B-2 Preferred Shares | Disposition | 2018-05-30 | 1,591 | $0.00 | 1,591 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- Not applicable.
Billionaire Hedge Funds
